Select a second ETF to benchmark against RBC Life Science and Technology Fund (RLST). Compare key metrics including year-to-date performance, management fees, sector exposures and underlying assets to ensure you are selecting the best fund for your investment objectives.
NAV Performance and Flows
Key Data
Compare
RLST
| AuM | $29.51 M | |
| Management Fees | 0.75% | |
| Exp. ratio | 0.94% | |
| Tracking Difference | - |
Historical performance and flows
As of October 30, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | RLST | -7.52% | +1.64% | +13.66% | +10.27% | - |
| Flows | RLST | +$1 M | +$1 M | +$8 M | +$9 M | - |
Exposure
Countries
RLST
Exposure data will be available soon
Sectors
RLST
Exposure data will be available soon
As of October 30, 2026
Top 10 Holdings
RLST
Exposure data will be available soon
Diversification
RLST
Exposure data will be available soon
Characteristics
Compare
RLST
| Provider | RBC Global Asset Management | |
| Management | Actively managed | |
| Benchmark | - | |
| Replication Method | - | |
| Asset Class | Equity | |
| Dividend Policy | Distributing | |
| Trailing 12m distribution yield | 0.00% | |
| Meets ESG criteria | No | |
| Inception Date | September 18, 2024 |
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.